The skilled trades gap is no longer a future concern. In mechanical and electrical systems, the impact is already visible.

The board will search for a replacement leader for the fund, which launched in August with a $3.1 billion endowment.

Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary ...